Philip J R Goulder Selected Research

protease p15

2/2002

Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip J R Goulder Research Topics

Disease

36	Infections 11/2021 - 02/2002
13	HIV Infections (HIV Infection) 07/2022 - 04/2003
11	Disease Progression 12/2020 - 12/2004
7	Viremia 07/2022 - 12/2003
3	Coinfection 01/2019 - 04/2017
3	Virus Diseases (Viral Diseases) 01/2017 - 08/2004
2	Communicable Diseases (Infectious Diseases) 07/2014 - 09/2012
1	Disease Susceptibility (Diathesis) 11/2021
1	Tuberculosis (Tuberculoses) 01/2019
1	Superinfection 01/2018
1	Hepatitis C 09/2014
1	Hepatitis B 09/2014
1	Liver Diseases (Liver Disease) 09/2014
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2010
1	Persistent Infection 10/2010
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2007
1	Acute-Phase Reaction 07/2004
1	Human Influenza (Influenza) 04/2004
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 09/2002

Drug/Important Bio-Agent (IBA)

22	EpitopesIBA 11/2017 - 02/2002
15	HLA-B Antigens (HLA-B)IBA 11/2021 - 12/2004
8	VaccinesIBA 01/2019 - 02/2002
4	Antiviral Agents (Antivirals)IBA 01/2018 - 05/2011
4	Proteins (Proteins, Gene)FDA Link 11/2017 - 02/2002
4	HLA-B57 antigenIBA 04/2017 - 06/2005
4	Peptides (Polypeptides)IBA 01/2009 - 09/2002
3	HLA-A Antigens (HLA-A)IBA 11/2021 - 12/2004
3	CytokinesIBA 01/2019 - 01/2009
3	AntibodiesIBA 01/2018 - 10/2010
3	Amino Acids FDA Link 01/2018 - 04/2004
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017 - 09/2002
3	RNA (Ribonucleic Acid)IBA 09/2015 - 12/2003
3	AIDS VaccinesIBA 09/2015 - 08/2004
2	Immunoglobulin G (IgG)IBA 01/2018 - 04/2017
2	ProteomeIBA 04/2017 - 01/2008
2	Peptide Hydrolases (Proteases)FDA Link 04/2011 - 10/2010
2	Interferon-gamma (Interferon, gamma)IBA 01/2009 - 04/2004
2	HLA-A3 Antigen (HLA A3 Antigen)IBA 07/2004 - 09/2002
1	Nucleic AcidsIBA 07/2022
1	Immunoglobulin Fc FragmentsIBA 12/2020
1	Broadly Neutralizing AntibodiesIBA 12/2020
1	Interleukin-2 (IL2)IBA 01/2019
1	InterferonsIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 04/2017
1	gag Gene Products (gag Protein)IBA 01/2016
1	Gonadal Steroid Hormones (Sex Hormones)IBA 07/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2012
1	Interleukin-10 (Interleukin 10)IBA 01/2012
1	Green Fluorescent ProteinsIBA 04/2011
1	Rituximab (Mabthera)FDA Link 10/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2008
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2007
1	Cyclophilin AIBA 11/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2007
1	HLA-B58IBA 08/2005
1	Immunodominant EpitopesIBA 04/2005
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 04/2005
1	AntigensIBA 04/2004
1	nef Gene Products (nef Gene Product)IBA 04/2003
1	protease p15IBA 02/2002

Therapy/Procedure

5	Art Therapy 01/2022 - 09/2011
3	Therapeutics 01/2011 - 12/2003
2	Highly Active Antiretroviral Therapy (HAART) 07/2022 - 12/2003